Korean Sunscreens Show Superior UVB Protection in Consumer Reports Study
Consumer Reports conducted a head-to-head comparison of Korean and U.S. versions of popular K-beauty sunscreens, finding that the Korean formulas offered superior protection, particularly against UVB rays. The difference in regulation, with the U.S. FDA treating sunscreen as a drug…
Minneapolis St. Paul, MN, August 10, 2026 —
A recent head-to-head comparison by Consumer Reports has found that Korean versions of popular K-beauty sunscreens provide superior protection, especially against UVB rays, compared to their U.S. counterparts.
The study highlights a key difference in regulatory approaches between the United States and South Korea. In the U.S., the Food and Drug Administration (FDA) classifies sunscreen as a drug, a designation that involves a more rigorous approval process. Conversely, South Korea categorizes sunscreen as a cosmetic, allowing for a wider range of ingredients to be used.
This regulatory distinction means that some of the Korean sunscreens tested by Consumer Reports, which utilize ingredients not yet approved by the U.S. FDA, are not legally available for sale in the United States. However, the landscape is evolving, with the FDA reportedly approving new sunscreen ingredients, such as bemotrizinol, which is already in use in other countries.
Despite the findings regarding Korean formulas, Consumer Reports continues to recommend sunscreens that are legally available in the U.S. and meet established protection standards. Among the recommended products are Coppertone Water Babies Lotion SPF 50 and Eucerin Advanced Hydration Spray SPF 50. The organization stresses the critical importance of using broad-spectrum sunscreens with an SPF of at least 30 and reapplying them regularly to ensure adequate sun protection.
Story summarized from the original created by Joseph Swanson on kstp.com, see more information here.
